Calithera Biosciences
Developing novel small molecule therapeutics for the treatment of cancer.
Launch date
Employees
Market cap
CAD332k
Enterprise valuation
(CAD2m) (Public information from Sep 2024)
Share price
$0.02 CALA
South San Francisco California (HQ)
Authorizing premium user...